Trial Profile
Non-interventional Study to Observe Efficacy and Usage of Quetiapine in Acute Episodes of Schizophrenia and as Maintenance Therapy Following Standard Clinical Practice in Croatia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Sep 2020
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 07 Jan 2011 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
- 07 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Apr 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.